Grand rounds: Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians

Please join us for grand rounds on Thursday, May 19, from 12:00-1:00pm ET. Elizabeth Bayliss, MD, of the IMPACT Health Care Systems (HCS) Core, and Cynthia Boyd, MD, US Deprescribing Research Network (USDeN) co-director, will discuss “Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMZE Pragmatic Cluster Randomized Trial.”